US Patent Issued to Intervet on May 26 for "Swine influenza a virus vaccine comprising two distinct RNA replicon particles" (Dutch, American Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,359, issued on May 26, was assigned to Intervet Inc. (Rahway, N.J.).

"Swine influenza a virus vaccine comprising two distinct RNA replicon particles" was invented by Mark A. Mogler (Ames, Iowa) and Basav Hangalapura Nagaraj (Wageningen, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an immunogenic composition comprising first and second RNA replicon particles. The first RNA replicon particle comprises a nucleic acid construct comprising first and second nucleic acid sequences encoding first and second hemagglutinin (HA) antigens of a Swine influenza A virus (IAV-S). The first HA antigen is a of the A/swine...